Trial Information

Summary: A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).

Participants must meet the following criteria:

• Females 45-75 years old
• Five years postmenopausal
• Have mild to moderate osteoporosis (BMD T-Score from -2.0 to -4.0)
• Must be willing to have a non-invasive bone density test (BMD)
• Not be on any osteoporosis medications (e.g. Didrocal, Fosamax, Actonel, Hormone Replacement Therapy)
• Capable of understanding and giving written, voluntary informed consent
• Able to come to the study clinic for your visits
• Have no more than one fragility fracture

For further information, kindly call the nearest study coordinator:

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:45:18 AM